Remodeling of the fovea in Parkinson disease

Journal of Neural Transmission

Volumn 120, Issue 5, 2013, Pages 745-753

  Spund, B ^a   Ding, Y ^c   Liu, T ^c   Selesnick, I ^c   Glazman, S ^a   Shrier, E M ^a,b   Bodis Wollner, I ^a,b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b SUNY EYE INSTITUTE   (United States)

^c POLYTECHNIC UNIVERSITY   (United States)

Author keywords

Dopaminergic neurons; Foveal avascular zone (FAZ); Optical coherence tomography (OCT); Parkinson disease (PD); Receiver operating characteristics (ROC); Retinal foveal pit

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMAGE ANALYSIS; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETINA FOVEA; RETINA NERVE CELL; RETINAL NERVE FIBER LAYER THICKNESS; SENSITIVITY AND SPECIFICITY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY;

AREA UNDER CURVE; FEMALE; FOURIER ANALYSIS; FOVEA CENTRALIS; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; RETINA; ROC CURVE; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84878017678     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-012-0909-5     Document Type: Article

References (51)

1. Aaker GD, Myung JS, Ehrlich JR et al (2008) Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. Clin Ophthalmol 4:1427-1432
2. Altintas O, Iseri P, Ozkan B, Caglar Y (2008) Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Documenta Ophthal 1116:137-146
3. Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2009) The retina in Parkinson's disease. Brain 132(Pt 5):1128-1145
4. Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2011) Retinal thickness in Parkinson's disease. Parkinsonism Relat Disord. 17(6):431-436 (Epub 2011 Mar 31)
5. Bagci AM, Shahidi M, Ansari R et al (2008) Thickness profiles of retinal layers by optical coherence tomography image segmentation. Am J Ophthalmol 146:679-687
6. Biehlmaier O, Alam M, Schmidt WJ (2007) A rat model of Parkinsonism shows depletion of dopamine in the retina. NeurochemInt 50:189-195
7. Bodis-Wollner I (1990) Visual deficit related to dopamine deficiency in experimental animals and Parkinson's disease. Trends Neurosci 13:296-301
8. Bodis-Wollner I (2009) Retinopathy in Parkinson disease. J Neural Transm 116:1493-1501
9. Bodis-Wollner I (2012) Foveal vision is impaired in Parkinson's disease. A review. Parkinsonism Relat Disord pii: S1353-8020(12):295-297. doi: 10.1016/j.parkreldis.2012.07.012 [Epub ahead of print]
10. Bodis-Wollner I, Harnois C, Bobak P, Mylin LH (1983) On the possible role oftemporal delays of afferent processing in Parkinson's disease. J Neural Trans Suppl 19:243-252
11. Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rüb U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 249:1-5
12. Chui TY, Zhong Z, Song H, Burns SA (2012) Foveal avascular zone and its relationship to foveal pit shape. Optom Vis Sci 89(5):602-610
13. Cubo E, Tedejo RP, Rodriguez Mendez V et al (2010) Retinal thickness in Parkinson's disease and essential tremor. Mov Disord 25:2461-2462
14. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837-845
15. Djamgoz MB, Hankins MW, Hirano J, Archer SN (1997) Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vis Res 37:3509-3529
16. Dowling JE, Ehinger B (1978) Synaptic organization of the dopaminergic neurons in the rabbit retina. J Comp Neurol 180:203-220
17. Dubis AM, Hansen BR, Cooper RF et al (2012) The relationship between the foveal avascular zone and foveal pit morphology. Invest Ophthalmol Vis Sci 53(3):1628
18. Engle RF (1983) Wald, likelihood ratio, and lagrange multiplier tests in econometrics. In: Intriligator MD, Griliches Z (eds) Handbook of econometrics II, pp 796-801. Elsevier. ISBN978-0-444-86185-6
19. Esteve-Rudd J, Campello L, Herrero MT et al (2010) Expression in the mammalian retina of parkin and UCH-L1, two components of the ubiquitin-proteasome system. Brain Res 1352:70-82
20. Frederick JM, Rayborn ME, Laties AM et al (1982) Dopaminergic neurons in the human retina. J Comp Neurol 210:65-79
21. Ghilardi MF, Chung E, Bodis-Wollner I et al (1988) Systemic 1-methyl, 4-phenyl 1-2-3-6 tetrahydropyridine (MPTP) administration decreases retinal dopamine concentration in primates. Life Sci 4(3):255-6263
22. Ghilardi MF, Marx MS, Bodis-Wollner I, Camras CB, Glover AA (1989) The effect of intraocular 6-hydroxydopamine on retinal processing of primates. Ann Neurol 25:357-364
23. Gottlob I, Weghaupt H, Vass C, Auff E (1989) Effect of levodopa on the human pattern electroretinogram and pattern visual evoked potentials. Graefes Arch Clin Exp Ophthalmol 227:421-427
24. Hajee M, March W, Wolintz A et al (2009) Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 127:737-741
25. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36
26. Harnois C, DiPaolo T (1990) Decreased dopamine in the retinas of patients with Parkinson disease. Invest Ophthalmol Vis Sci 31:2473-2475
27. Hendley ED, Snyder SH (1972) Stereoselectivity of catecholamine uptake in noradrenergic and dopaminergic peripheral organs. Eur J Pharmacol 19:56-66
28. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427-442
29. Hokoc JN, Mariani AP (1987) Tyrosine hydroxylase immunoreactivity in the rhesus monkey retina reveals synapses from bipolar cells to dopaminergic amacrine cells. J Neurosci 7(9):2785-2793
30. Huang D, Swanson EA, Lin CP et al (1991) Optical coherence tomography. Science 254:1178-1181
31. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184
32. Ikeda H, Head GM, Ellis CJ (1994) Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson's disease and a follow up study. Vis Res 34:2629-2638
33. Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A (2004) Retinal nerve fiber layer thinning in Parkinson disease. Vis Res 44:2793-2797
34. La Morgia C, Carbonelli M, Barboni P (2011) Age-related temporal loss of retinal nerve fibers in Parkinson disease: a mitochondrial pattern? Invest Ophthalmol Vis Sci 52. E-Abstract 2984. Eur J Neurol. doi: 10.1111/j.1468-1331. 2012.03701.x (Epub ahead of print)
35. Loduca AL, Zhana CHI, Zelkha R, Shahidi M (2010) Thickness mapping of retinal layers with spectral-domain optical coherence tomography. Am J Ophthalmol 150:849-855
36. Mariani AP, Hokoc JN (1988) Two types of tyrosine hydroxylase- immunoreactive amacrine cell in the rhesus monkey retina. J Comp Neurol 276(1):81-91
37. Martínez-Navarrete GC, Martín-Nieto J, Esteve-Rudd J et al (2007) Alpha synuclein gene expression profile in the retina of vertebrates. Mol Vis 13(949-61):32
38. Moschos MM et al (2011) Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol 21:24-29
39. Nguyen-Legros J (1998) Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease. Surg Radiol Anat 10:137-144
40. Peppe A, Stanzione P, Pierantozzi M et al (1998) Does pattern electroretinogram spatial tuning alteration in Parkinson's disease depends on motor disturbances or retinal dopaminergic loss? Electroencephalogr Clin Neurophysiol 106:374-382
41. Provis JM, Hendrickson AE (2008) The foveal avascular region of developing human retina. Arch Ophthalmol 126:507-511
42. Sartucci F, Orlandi G, Bonuccelli U, Borghetti D, Murri L, Orsini C et al (2006) Chromaticpattern-reversal electroretinograms (ChPERGs) are spared in multiple system atrophycompared with Parkinson's disease. Neurol Sci 26(6):395-401
43. Stanzione P, Fattapposta F, Tagliati M, D'Alessio C, Marciani MG, Foti A et al (1990) Dopaminergic pharmacological manipulations in normal humans confirm the specificity of the visual (PERG-VEP) and cognitive (P300) electrophysiological alterations in Parkinson's disease. Electroencephalogr Clin Neurophysiol Suppl 41:216-220
44. Tagliati M, Bodis-Wollner I, Kovanecz I, and Stanzione P (1994) Spatial frequency tuning of the monkey pattern ERG depends on D2 receptor-linked action of dopamine. Vision Res 34:2051-2057
45. Tagliati M, Bodis-Wollner I, Yahr M (1995) The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning. Electoenceph Clin Neurophysiol 100:1-11
46. Tan JM, Wong ES, Lim KL (2009) Protein misfolding and aggregation in Parkinson's disease. Antioxid Redox Signal 11:2119-2134
47. Tick S, Rossant F, Ghorbel I et al (2011) Foveal shape and structure in a normal population. Invest Ophthalmol Vis Sci 52:5105-5110
48. Wagner-Schuman M et al (2011) Race- and sex-related differences in retinal thickness and foveal pit morphology. Invest Ophthalmol Vis Sci 52:625-634
49. Witkovsky P (2004) Dopamine and retinal function. Doc Ophthalmol 108(1):17-40
50. Witkovsky P, Gabriel R, Krizaj D (2008) Anatomical and neurochemical characterization of dopaminergic interplexiform processes in mouse and rat retinas. J Comp Neurol 510:158-174
51. Wojtkowski M, Bajraszewski T, Gorczynska I et al (2004) Ophthalmic imaging by spectral optical coherence tomography. Am J Ophthalmol 138:412-419